184 related articles for article (PubMed ID: 24798283)
1. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.
Gontijo AV; Brillault J; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
Antimicrob Agents Chemother; 2014 Jul; 58(7):3942-9. PubMed ID: 24798283
[TBL] [Abstract][Full Text] [Related]
2. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin.
Gontijo AV; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
Antimicrob Agents Chemother; 2014 Jul; 58(7):3950-6. PubMed ID: 24798284
[TBL] [Abstract][Full Text] [Related]
3. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 5. Oseltamivir Carboxylate.
Galindo Bedor DC; Marchand S; Lamarche I; Laroche J; Pereira de Santana D; Couet W
Antimicrob Agents Chemother; 2016 Aug; 60(8):5085-7. PubMed ID: 27297482
[TBL] [Abstract][Full Text] [Related]
5. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.
Capitano B; Mattoes HM; Shore E; O'Brien A; Braman S; Sutherland C; Nicolau DP
Chest; 2004 Mar; 125(3):965-73. PubMed ID: 15006955
[TBL] [Abstract][Full Text] [Related]
6. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
7. New aerosol formulation to control ciprofloxacin pulmonary concentration.
Lamy B; Tewes F; Serrano DR; Lamarche I; Gobin P; Couet W; Healy AM; Marchand S
J Control Release; 2018 Feb; 271():118-126. PubMed ID: 29277683
[TBL] [Abstract][Full Text] [Related]
8. Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis.
Ni W; Yang D; Mei H; Zhao J; Liang B; Bai N; Chai D; Cui J; Wang R; Liu Y
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115351
[TBL] [Abstract][Full Text] [Related]
9. A preclinical pharmacokinetic modeling approach to the biopharmaceutical characterization of immediate and microsphere-based sustained release pulmonary formulations of rifampicin.
Doan TV; Grégoire N; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC
Eur J Pharm Sci; 2013 Jan; 48(1-2):223-30. PubMed ID: 23159665
[TBL] [Abstract][Full Text] [Related]
10. Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Chugh R; Gupta M; Yeole R; Patel A; Bhatia A
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263070
[TBL] [Abstract][Full Text] [Related]
11. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.
Hawkins EC; Boothe DM; Guinn A; Aucoin DP; Ngyuen J
J Vet Pharmacol Ther; 1998 Feb; 21(1):18-23. PubMed ID: 9507453
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 6. Aminoglycosides.
Marchand S; Boisson M; Mehta S; Adier C; Mimoz O; Grégoire N; Couet W
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082284
[TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.
Shandil RK; Jayaram R; Kaur P; Gaonkar S; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharath S; Balasubramanian V
Antimicrob Agents Chemother; 2007 Feb; 51(2):576-82. PubMed ID: 17145798
[TBL] [Abstract][Full Text] [Related]
14. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.
Rodvold KA; George JM; Yoo L
Clin Pharmacokinet; 2011 Oct; 50(10):637-64. PubMed ID: 21895037
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients.
Boisson M; Mimoz O; Hadzic M; Marchand S; Adier C; Couet W; Grégoire N
J Antimicrob Chemother; 2018 Oct; 73(10):2830-2837. PubMed ID: 29947799
[TBL] [Abstract][Full Text] [Related]
16. Proposal of membrane transport mechanism of protein-unbound ulifloxacin into epithelial lining fluid determined by improved microdialysis.
Aoki M; Iguchi M; Hayashi H; Suzuki H; Shibasaki S; Kurosawa T; Hayashi M
Biol Pharm Bull; 2008 Sep; 31(9):1773-7. PubMed ID: 18758075
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary pharmacokinetics of levofloxacin in rats after aerosolization of immediate-release chitosan or sustained-release PLGA microspheres.
Gaspar MC; Grégoire N; Sousa JJ; Pais AA; Lamarche I; Gobin P; Olivier JC; Marchand S; Couet W
Eur J Pharm Sci; 2016 Oct; 93():184-91. PubMed ID: 27531420
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic efficacy of intrapulmonary administration of ciprofloxacin for the treatment of respiratory infections.
Chono S; Tanino T; Seki T; Morimoto K
Drug Metab Pharmacokinet; 2007 Apr; 22(2):88-95. PubMed ID: 17495415
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic modeling to establish the role of P-glycoprotein on ciprofloxacin distribution to lung and prostate following intravenous and intratracheal administration to Wistar rats.
Zimmermann ES; de Miranda Silva C; Neris C; Torres BGDS; Schmidt S; Dalla Costa T
Eur J Pharm Sci; 2019 Jan; 127():319-329. PubMed ID: 30423435
[TBL] [Abstract][Full Text] [Related]
20. Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin.
Rodríguez-Ibáñez M; Sánchez-Castaño G; Montalar-Montero M; Garrigues TM; Bermejo M; Merino V
Int J Pharm; 2006 Jan; 307(1):33-41. PubMed ID: 16257153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
